- Home
- BW vs GALT Comparison
BW vs GALT Comparison
Compare BW & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- GALT
- Stock Information
- Founded
- BW 1867
- GALT 2000
- Country
- BW United States
- GALT United States
- Employees
- BW N/A
- GALT N/A
- Industry
- BW Building Products
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- BW Industrials
- GALT Health Care
- Exchange
- BW Nasdaq
- GALT Nasdaq
- Market Cap
- BW 95.7M
- GALT 83.5M
- IPO Year
- BW N/A
- GALT N/A
- Fundamental
- Price
- BW $1.04
- GALT $2.79
- Analyst Decision
- BW Strong Buy
- GALT Buy
- Analyst Count
- BW 1
- GALT 2
- Target Price
- BW $5.00
- GALT $6.00
- AVG Volume (30 Days)
- BW 816.2K
- GALT 664.5K
- Earning Date
- BW 08-07-2025
- GALT 08-12-2025
- Dividend Yield
- BW N/A
- GALT N/A
- EPS Growth
- BW N/A
- GALT N/A
- EPS
- BW N/A
- GALT N/A
- Revenue
- BW $734,239,000.00
- GALT N/A
- Revenue This Year
- BW $5.81
- GALT N/A
- Revenue Next Year
- BW $9.24
- GALT N/A
- P/E Ratio
- BW N/A
- GALT N/A
- Revenue Growth
- BW 12.90
- GALT N/A
- 52 Week Low
- BW $0.22
- GALT $0.73
- 52 Week High
- BW $2.99
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- BW 55.15
- GALT 68.94
- Support Level
- BW $0.99
- GALT $2.77
- Resistance Level
- BW $1.10
- GALT $2.97
- Average True Range (ATR)
- BW 0.06
- GALT 0.20
- MACD
- BW -0.01
- GALT 0.04
- Stochastic Oscillator
- BW 70.59
- GALT 91.11
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.